---
figid: PMC7794044__fuaa044fig4
figlink: pmc/articles/PMC7794044/figure/fig4/
number: F4
caption: 'Signalling pathways activated by peptidoglycan upon stimulation of NOD-like
  receptors. The canonical pathway of muropeptide-mediated NOD1/NOD2 activation ultimately
  culminates with the activation of the transcription factor NF-κB and the expression
  of its target genes. The NOD1 or NOD2 CARD domains interact first through homotypic
  CARD-CARD interactions with the CARD-containing kinase RIPK2/RICK. The NBDs recruit
  additional players, including proteins that regulate the ubiquitination-mediated
  signal transduction cascade that leads NF-κB activation. These players may either
  positively (e.g. TRAF6, cIAP1 and 2) or negatively (e.g. Caspase 12, A20) modulate
  NOD receptor activation and subsequent signalling. In response to their muropeptide
  ligands, NOD1 and NOD2 activation can also signal through RIPK2/RICK-independent
  mechanisms. RIPK2/RICK-independent signalling occurs downstream of NOD2 activation
  upon binding to CARD9. Whilst this leads to the activation of MAPKs, other RIPK2/RICK-independent
  pathways exist which do not result in the activation of either MAPKs, NF-κB or IRF7.
  In this case, NOD1 and NOD2 interact with other NLRs. For instance, NOD2 has been
  shown to specifically and directly interact with and drive downstream signalling
  via NLRP1, NLRP3 and NLRP12. Interaction of NOD2 with NLRP3 activates ASC, which
  in turn activates caspase 1 and leads to the production of IL-1β. Similarly, NOD1
  recruitment to the membrane is accompanied by ATG16L1 recruitment and activation,
  which in turn leads to activation of the autophagy process (which may be RIPK2/RICK-dependent
  or independent). Hexokinase is an enzyme that participates in glycolysis by catalyzing
  the conversion of glucose to glucose-6-phosphate. N-acetylglucosamine generated
  by peptidoglycan degradation (likely within endosomes/lysosomes) binds mitochondrial
  outer membrane-associated hexokinase (H), inducing its release and the liberation
  of its interacting partners (e.g. voltage-dependent anion channel VDAC, Akt). Following
  a multistep process that involves (among other events) the release of mitochondrial
  DNA, the NLRP3 inflammasome is activated, pro caspase-1 converted into caspase-1,
  and pro Il-1β converted into active IL-1β. This hexokinase-mediated NLRP3 inflammasome
  activation is independent of NOD1 and NOD2 receptors. A20: alpha-induced protein
  3; ASC: apoptosis-associated speck-like protein containing a CARD; ATG16L1: autophagy
  related 16 like 1; cIAP: cellular inhibitor of apoptosis; eRK: extracellular signal-regulated
  kinase; IRF7: interferon regulatory transcription factor 7; JNK: c-Jun N-terminal
  kinase; MAPK: mitogen-activated protein kinase; NF-κB: nuclear factor-kappa B; NLRP:
  nucleotide-binding oligomerization domain, leucine rich repeat and pyrin domain
  containing; NOD: nucleotide oligomerization domain; RIPK2/RICK: receptor-interacting
  serine/threonine-protein kinase 2.'
pmcid: PMC7794044
papertitle: Uptake, recognition and responses to peptidoglycan in the mammalian host.
reftext: Paulo A D Bastos, et al. FEMS Microbiol Rev. 2021 Jan;45(1):fuaa044.
pmc_ranked_result_index: '60413'
pathway_score: 0.9704873
filename: fuaa044fig4.jpg
figtitle: Signalling pathways activated by peptidoglycan upon stimulation of NOD-like
  receptors
year: '2021'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7794044__fuaa044fig4.html
  '@type': Dataset
  description: 'Signalling pathways activated by peptidoglycan upon stimulation of
    NOD-like receptors. The canonical pathway of muropeptide-mediated NOD1/NOD2 activation
    ultimately culminates with the activation of the transcription factor NF-κB and
    the expression of its target genes. The NOD1 or NOD2 CARD domains interact first
    through homotypic CARD-CARD interactions with the CARD-containing kinase RIPK2/RICK.
    The NBDs recruit additional players, including proteins that regulate the ubiquitination-mediated
    signal transduction cascade that leads NF-κB activation. These players may either
    positively (e.g. TRAF6, cIAP1 and 2) or negatively (e.g. Caspase 12, A20) modulate
    NOD receptor activation and subsequent signalling. In response to their muropeptide
    ligands, NOD1 and NOD2 activation can also signal through RIPK2/RICK-independent
    mechanisms. RIPK2/RICK-independent signalling occurs downstream of NOD2 activation
    upon binding to CARD9. Whilst this leads to the activation of MAPKs, other RIPK2/RICK-independent
    pathways exist which do not result in the activation of either MAPKs, NF-κB or
    IRF7. In this case, NOD1 and NOD2 interact with other NLRs. For instance, NOD2
    has been shown to specifically and directly interact with and drive downstream
    signalling via NLRP1, NLRP3 and NLRP12. Interaction of NOD2 with NLRP3 activates
    ASC, which in turn activates caspase 1 and leads to the production of IL-1β. Similarly,
    NOD1 recruitment to the membrane is accompanied by ATG16L1 recruitment and activation,
    which in turn leads to activation of the autophagy process (which may be RIPK2/RICK-dependent
    or independent). Hexokinase is an enzyme that participates in glycolysis by catalyzing
    the conversion of glucose to glucose-6-phosphate. N-acetylglucosamine generated
    by peptidoglycan degradation (likely within endosomes/lysosomes) binds mitochondrial
    outer membrane-associated hexokinase (H), inducing its release and the liberation
    of its interacting partners (e.g. voltage-dependent anion channel VDAC, Akt).
    Following a multistep process that involves (among other events) the release of
    mitochondrial DNA, the NLRP3 inflammasome is activated, pro caspase-1 converted
    into caspase-1, and pro Il-1β converted into active IL-1β. This hexokinase-mediated
    NLRP3 inflammasome activation is independent of NOD1 and NOD2 receptors. A20:
    alpha-induced protein 3; ASC: apoptosis-associated speck-like protein containing
    a CARD; ATG16L1: autophagy related 16 like 1; cIAP: cellular inhibitor of apoptosis;
    eRK: extracellular signal-regulated kinase; IRF7: interferon regulatory transcription
    factor 7; JNK: c-Jun N-terminal kinase; MAPK: mitogen-activated protein kinase;
    NF-κB: nuclear factor-kappa B; NLRP: nucleotide-binding oligomerization domain,
    leucine rich repeat and pyrin domain containing; NOD: nucleotide oligomerization
    domain; RIPK2/RICK: receptor-interacting serine/threonine-protein kinase 2.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ATG16L1
  - NOD2
  - RIPK2
  - TRAF6
  - CARD9
  - CASP1
  - CASP2
  - CASP8
  - CASP9
  - CASP14
  - CASP12
  - CASP3
  - CASP4
  - CASP5
  - CASP6
  - CASP7
  - CASP10
  - TNFAIP3
  - NLRP1
  - NLRP3
  - IRF7
  - NLRP12
  - NFKB1
  - NFKB2
  - REL
  - RELA
  - RELB
  - MAPK8
  - MAPK9
  - MAPK10
  - MAPK3
  - MAPK1
  - IFNA1
  - IFNA2
  - IFNA4
  - IFNA5
  - IFNA7
  - IFNA8
  - IFNA17
  - IFNB1
  - IFNA6
  - IFNA10
  - IFNA13
  - IFNA14
  - IFNA16
  - IFNA21
  - IFNW1
  - IFNK
  - PYCARD
  - IL1B
  - MDP
genes:
- word: ATG16L1
  symbol: ATG16L1
  source: hgnc_symbol
  hgnc_symbol: ATG16L1
  entrez: '55054'
- word: NOD2
  symbol: NOD2
  source: hgnc_symbol
  hgnc_symbol: NOD2
  entrez: '64127'
- word: RIPK2-independent
  symbol: RIPK2
  source: hgnc_symbol
  hgnc_symbol: RIPK2
  entrez: '8767'
- word: TRAF6
  symbol: TRAF6
  source: hgnc_symbol
  hgnc_symbol: TRAF6
  entrez: '7189'
- word: CARD9
  symbol: CARD9
  source: hgnc_symbol
  hgnc_symbol: CARD9
  entrez: '64170'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP1
  entrez: '834'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP2
  entrez: '835'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP9
  entrez: '842'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP14
  entrez: '23581'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP12
  entrez: '100506742'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP4
  entrez: '837'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP5
  entrez: '838'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP6
  entrez: '839'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP7
  entrez: '840'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP10
  entrez: '843'
- word: RIPK2/RICK
  symbol: RIPK2
  source: hgnc_symbol
  hgnc_symbol: RIPK2
  entrez: '8767'
- word: RIPK2/RICK
  symbol: RICK
  source: hgnc_alias_symbol
  hgnc_symbol: RIPK2
  entrez: '8767'
- word: A20
  symbol: A20
  source: hgnc_alias_symbol
  hgnc_symbol: TNFAIP3
  entrez: '7128'
- word: NLRP1
  symbol: NLRP1
  source: hgnc_symbol
  hgnc_symbol: NLRP1
  entrez: '22861'
- word: NLRP3
  symbol: NLRP3
  source: hgnc_symbol
  hgnc_symbol: NLRP3
  entrez: '114548'
- word: IRF7
  symbol: IRF7
  source: hgnc_symbol
  hgnc_symbol: IRF7
  entrez: '3665'
- word: RIPK2-dependent
  symbol: RIPK2
  source: hgnc_symbol
  hgnc_symbol: RIPK2
  entrez: '8767'
- word: NLRP12
  symbol: NLRP12
  source: hgnc_symbol
  hgnc_symbol: NLRP12
  entrez: '91662'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: JNK]
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: JNK]
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: JNK]
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: '[p38,ERK1/2,JNK]'
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK1/2,
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK1/2,
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: RIPK2-independent
  symbol: RIPK2
  source: hgnc_symbol
  hgnc_symbol: RIPK2
  entrez: '8767'
- word: Interferon
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA1
  entrez: '3439'
- word: Interferon
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA2
  entrez: '3440'
- word: Interferon
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA4
  entrez: '3441'
- word: Interferon
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA5
  entrez: '3442'
- word: Interferon
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA7
  entrez: '3444'
- word: Interferon
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA8
  entrez: '3445'
- word: Interferon
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA17
  entrez: '3451'
- word: Interferon
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNB1
  entrez: '3456'
- word: Interferon
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA6
  entrez: '3443'
- word: Interferon
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA10
  entrez: '3446'
- word: Interferon
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA13
  entrez: '3447'
- word: Interferon
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA14
  entrez: '3448'
- word: Interferon
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA16
  entrez: '3449'
- word: Interferon
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA21
  entrez: '3452'
- word: Interferon
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNW1
  entrez: '3467'
- word: Interferon
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNK
  entrez: '56832'
- word: ASC
  symbol: ASC
  source: hgnc_alias_symbol
  hgnc_symbol: PYCARD
  entrez: '29108'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP1
  entrez: '834'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP2
  entrez: '835'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP9
  entrez: '842'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP14
  entrez: '23581'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP12
  entrez: '100506742'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP4
  entrez: '837'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP5
  entrez: '838'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP6
  entrez: '839'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP7
  entrez: '840'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP10
  entrez: '843'
- word: IL-1B
  symbol: IL-1B
  source: hgnc_alias_symbol
  hgnc_symbol: IL1B
  entrez: '3553'
chemicals:
- word: MDP
  source: MESH
  identifier: C041058
diseases: []
figid_alias: PMC7794044__F4
redirect_from: /figures/PMC7794044__F4
figtype: Figure
---
